Human Cell Lines
|
| Cell Line |
Tissue Type |
Origin |
Disease |
Culture Properties |
| Z138 |
B cell non-Hodgkin’s lymphoma |
Human |
Mantle cell lymphoma |
Suspension |
| KMS11 GFP |
B cell |
Human |
myeloma |
Suspension |
| KMS11 tdtomato-luc |
B cell |
Human |
myeloma |
Suspension |
| U-2932 |
B cell type-Activated |
Human |
B-cell lymphoma |
Suspension |
| RPMI 8226 |
B lymphocyte |
Human |
Myeloma |
Suspension |
| SU-DHL-4 |
B lymphocyte |
Human |
Lymphoma |
Suspension |
| SU-DHL-4 td tomato |
B lymphocyte |
Human |
Lymphoma |
Suspension |
| BC-1 |
B lymphocytes |
Human |
Lymphoma |
Suspension |
| BC1 Fluc |
B lymphocytes |
Human |
Lymphoma |
Suspension |
| Ramos |
B lymphocytes |
Human |
Burkitt’s lymphoma |
Suspension |
| Ramos tdtomato luc2 |
B lymphocytes |
Human |
Burkitt’s lymphoma |
Suspension |
| MG-63 |
Bone |
Human |
Osteosarcoma |
Adherent |
| SaOS-2 |
Bone |
Human |
Osteosarcoma |
Adherent |
| K562 |
Bone Marrow |
Human |
Chronic myelogenous leukemia |
Suspension |
| L-540 |
Bone marrow |
Human |
Hodgkin lymphoma |
Suspension |
| RS4;11 |
Bone marrow |
Human |
Acute lymphoblastic leukemia |
Suspension |
| GBM6 373871 |
Brain |
Human |
Glioblastoma; Primary |
|
| GBM6 tdtom luc2 SQ |
Brain |
Human |
Glioblastoma; Primary |
|
| HCN-2 |
Brain |
Human |
Encephalitis |
|
| IMR5 |
Brain |
Human |
Neuroblastoma |
Adherent |
| SF268 |
Brain |
Human |
Astrocytoma/glioma |
Adherent |
| SF295 |
Brain |
Human |
Astrocytoma/glioma |
Adherent |
| SF539 |
Brain |
Human |
Glioblastoma |
Adherent |
| SK-N-BE(2) |
Brain |
Human |
Neuroblastoma |
Mixed adherent -suspension |
| SKND2 |
Brain |
Human |
Neuroblastoma |
Adherent |
| SK-N-DZ |
Brain |
Human |
Neuroblastoma |
Adherent |
| SNB19 |
Brain |
Human |
Astrocytoma |
Adherent |
| SNB-75 |
Brain |
Human |
Glioblastoma |
Adherent |
| U251 |
Brain |
Human |
Astrocytoma |
Adherent |
| U87 |
Brain |
Human |
Glioblastoma |
Adherent |
| GILM2 |
Breast |
Human |
Breast carcinoma |
Adherent |
| GILM2 (L2T) pFU-luc2-tom |
Breast |
Human |
Breast carcinoma |
Adherent |
| MDA-MB-468 |
Breast metastatic site : pleural effusion |
Human |
Adenocarcinoma |
Adherent |
| M6 |
Breast; Mammary gland |
Human |
Carcinoma; Ductal |
|
| HeLa |
Cervix |
Human |
Adenocarcinoma |
Adherent |
| COLO 205 |
Colon |
Human |
Dukes’ type C, colorectal adenocarcinoma |
Mixed adherent -suspension |
| HCC-2998 |
Colon |
Human |
Adenocarcinnoma |
Adherent |
| HCT-15 |
Colon |
Human |
Dukes’ type C, colorectal adenocarcinoma |
Adherent |
| HT29 |
Colon |
Human |
Colorectal adenocarcinoma |
Adherent |
| KM12 |
Colon |
Human |
Colon cancer |
Adherent |
| RKO |
Colon |
Human |
Carcinoma |
Adherent |
| SW620 |
Colon |
Human |
Dukes’ type C, colorectal adenocarcinoma |
Adherent |
| HCT116 |
Colon |
Human |
Colorectal Carcinoma |
Adherent |
| HT-1080 |
Connective tissue |
Human |
Fibrosarcoma |
Adherent |
| HT-1080 myco + |
Connective tissue |
Human |
Fibrosarcoma |
Adherent |
| HuT 78 |
Cutaneous T cell |
Human |
Sezary Syndrome |
Suspension |
| ACC 257 (Colo-783) |
Derived from right axillary lymph node |
Human |
Malignant Melanoma/skin |
|
| Hek 293 m7-1 |
Embryonic kidney |
Human |
|
Adherent |
| M4A4 GFP |
epithelial cell |
Human |
breast cancer |
Adherent |
| KB |
HeLa contaminant |
Human |
Carcinoma, Papilloma |
|
| 786-O |
Kidney |
Human |
Renal cell carcinoma |
Adherent |
| A498 |
Kidney |
Human |
Carcinoma |
Adherent |
| ACHN |
Kidney |
Human |
Renal cell adenocarcinoma |
Adherent |
| CAKI |
Kidney |
Human |
Clear cell carcinoma |
Adherent |
| CAKI-2 |
Kidney |
Human |
Clear cell carcinoma |
Adherent |
| NCI TK-10 |
Kidney |
Human |
Renal cell carcinoma |
Adherent |
| RXF 393 NCI |
Kidney |
Human |
Renal cell carcinoma |
Adherent |
| SN12C |
Kidney |
Human |
Renal cell carcinoma |
Adherent |
| TK10 |
Kidney |
Human |
Renal cell carcinoma |
|
| U031 |
Kidney |
Human |
Carcinoma |
Adherent |
| SW403 |
Large intestine; Colon |
Human |
Adenocarcinoma; Colorectal; Dukes’ type C, grade III |
|
| SW480 |
Large intestine; Colon |
Human |
Adenocarcinoma; Colorectal; Dukes’ type B |
|
| HepG2 |
Liver |
Human |
Hepatocellular carcinoma |
Adherent |
| Huh7 |
Liver |
Human |
Carcinoma |
Adherent |
| A549 |
Lung |
Human |
Carcinoma |
Adherent |
| Calu-1 |
Lung |
Human |
Grade III, epidermoid carcinoma |
Adherent |
| H322M |
Lung |
Human |
Carcinoma |
Adherent |
| H522 |
Lung |
Human |
Stage 2 adenocarcinoma; non-small cell lung cancer |
Adherent |
| Hep26 |
Lung |
Human |
|
|
| M9K |
Lung |
Human |
Mesothelioma |
Adherent |
| MALME-3M NCI |
Lung |
Human |
Malignant melanoma |
Mixed adherent-suspension |
| NCI H1299 |
Lung |
Human |
Carcinoma; non-small cell lung cancer |
Adherent |
| NCI H226 |
Lung |
Human |
Squamous cell carcinoma; mesothelioma |
Adherent |
| NCI H441 |
Lung |
Human |
Papillary Adenocarcinoma |
|
| NCI-H460 |
Lung |
Human |
Carcinoma; large cell lung cancer |
Adherent |
| BEAS-2B |
Lung; Bronchus |
Human |
|
Adherent |
| U937 |
Lymphocyte |
Human |
Histiocytic lymphoma |
Suspension |
| BC-CAF |
Lymphoma |
Human |
Lymphoma |
Suspension |
| SUM1315 cherry |
mammary epithilial cells |
Human |
triple-negative basal-like (TNBL) breast cancer |
Adherent |
| BT-20 |
Mammary gland/breast |
Human |
Carcinoma |
Adherent |
| BT20 Cherry |
Mammary gland/breast |
Human |
Carcinoma |
Adherent |
| BT474 |
Mammary gland/breast |
Human |
Ductal carcinoma |
Adherent, patchy |
| BT549 |
Mammary gland/breast |
Human |
Ductal carcinoma |
Adherent |
| DU4475 |
Mammary gland/breast |
Human |
Carcinoma |
suspension, multicell aggregates |
| HCC-70 |
Mammary gland/breast |
Human |
Primary ductal carcinoma |
Adherent |
| HS 578T |
Mammary gland/breast |
Human |
Carcinoma |
Adherent |
| MCF 10A |
Mammary gland/breast |
Human |
Fibrocystic disease |
Adherent |
| MCF7 |
Mammary gland/breast |
Human |
Adenocarcinoma |
Adherent |
| MCF7 GFP |
Mammary gland/breast |
Human |
Adenocarcinoma |
Adherent |
| MDA231 LM24 Her+ |
Mammary gland/breast |
Human |
Adenocarcinoma |
|
| MDA231 LM24 parental |
Mammary gland/breast |
Human |
Adenocarcinoma |
|
| MDA231BR GFP |
Mammary gland/breast |
Human |
Adenocarcinoma |
|
| MDA-MB-231 |
Mammary gland/breast |
Human |
Adenocarcinoma |
Adherent |
| MDA-MB-231 lm24 |
Mammary gland/breast |
Human |
Adenocarcinoma |
Adherent |
| MDA-MB-231 LM24 Her- |
Mammary gland/breast |
Human |
Adenocarcinoma |
|
| MDA-MB-231 LM2-4 Tom Luc2 |
Mammary gland/breast |
Human |
Adenocarcinoma |
|
| MDA-MB-453 |
Mammary gland/breast |
Human |
Metastatic carcinoma |
Adherent |
| SKBR3 |
Mammary gland/breast |
Human |
Adenocarcinoma |
Adherent |
| HCC38 |
Mammary gland; breast/duct |
Human |
Primary ductal carcinoma |
Adherent |
| T-47D |
Mammary gland; metastatic site: pleural effusion |
Human |
Ductal carcinoma |
Adherent |
| MDA-MB-435 |
Metastatic site |
Human |
Melanoma |
Adherent |
| NCI LOX IMVI |
Metastatic site |
Human |
Melanoma |
Adherent |
| DU145 |
Metastatic site: Brain |
Human |
Prostate carcinoma |
Adherent |
| SF767 |
Metastatic site: Omentum |
Human |
Squamous cell carcinoma of the cervix |
Adherent |
| EKVX |
Non-small cell lung |
Human |
Adenocarcinoma |
Adherent |
| HOP-62 |
Non-small cell lung |
Human |
Adenocarcinoma |
Adherent |
| HOP-92 |
Non-small cell lung |
Human |
Adenocarcinoma |
Adherent |
| NCI-H23 |
Non-small cell lung |
Human |
Adenocarcinoma |
Adherent |
| NCI-H522 |
Non-small cell lung |
Human |
Stage 2 adenocarcinoma |
Adherent |
| A2780 |
ovary |
Human |
Carcinoma |
Adherent |
| Igrov1 |
Ovary |
Human |
Carcinoma |
Adherent |
| NCI-ADR-RES |
Ovary |
Human |
Adenocarcinoma |
Adherent |
| OVCAR-3 |
Ovary |
Human |
Adenocarcinoma |
Adherent |
| OVCAR-4 |
Ovary |
Human |
Adenocarcinoma |
Adherent |
| OVCAR-5 |
Ovary |
Human |
Adenocarcinoma |
Adherent |
| OVCAR-8 |
Ovary |
Human |
Adenocarcinoma |
Adherent |
| SK-OV-3 |
Ovary |
Human |
Adenocarcinoma |
Adherent |
| AsPC-1 |
Pancreas |
Human |
Adenocarcinoma |
Adherent |
| BxPC3 |
Pancreas |
Human |
Adenocarcinoma |
Adherent |
| L3.6.pL GFP+ |
Pancreas |
Human |
Pancreatic carcinoma |
Adherent |
| L3.6pl |
Pancreas |
Human |
Pancreatic carcinoma |
Adherent |
| MIA PaCa-2 |
Pancreas |
Human |
Carcinoma |
Adherent |
| Panc-1 |
Pancreas/duct |
Human |
Carcinoma |
Adherent |
| DND-41 luc |
Peripheral blood |
Human |
T-acute lymphoblastic leukemia |
Suspension |
| HH |
Peripheral Blood |
Human |
Cutaneous T cell lymphomoa |
Suspension |
| HL60 |
Peripheral Blood |
Human |
Acute promyelocytic leukemia |
Suspension |
| Jurkat |
Peripheral Blood |
Human |
Acute T cell leukemia |
Suspension |
| Jurkat luc GFP |
Peripheral Blood |
Human |
Acute T cell leukemia |
|
| Jurkat TIB152 |
Peripheral Blood |
Human |
Acute T cell leukemia |
|
| L363 |
Peripheral blood |
Human |
Leukemia |
Suspension |
| Mino |
Peripheral Blood |
Human |
Mantle cell lymphoma |
Suspension |
| MM.1R |
Peripheral Blood |
Human |
Multiple myeloma |
Mixed adherent-suspension |
| MM.1S |
Peripheral Blood |
Human |
Immunoglobulin A lambda myeloma |
Mixed adherent-suspension |
| MM.1S Luc Neo GFP |
Peripheral Blood |
Human |
Immunoglobulin A lambda myeloma |
Mixed adherent-suspension |
| MV411 |
Peripheral blood |
Human |
Biphenotic B myelomonocytic leukemia |
Suspension |
| MV411 luc neo |
Peripheral blood |
Human |
Biphenotic B myelomonocytic leukemia |
Suspension |
| OPM2 |
Peripheral blood |
Human |
Multiple myeloma |
Suspension |
| THP1 |
Peripheral blood |
Human |
Acute monocytic leukemia |
|
| CCRF-CEM |
Peripheral blood/ T lymphocyte |
Human |
Acute lymphoblastic leukemia |
Suspension |
| SU-DHL-6 |
Peritoneal effusion |
Human |
Large Cell Lymphoma |
|
| FaDu |
Pharynx |
Human |
Squamous cell carcinoma |
Adherent |
| JJN-3 |
Plasma cell |
Human |
Plasma cell leukemia |
Suspension |
| SR |
Pleural effusion |
Human |
Large cell immunoblastic lymphoma |
Suspension |
| 22rv1 SG |
Prostate |
Human |
Carcinoma |
Adherent |
| CWR22 |
Prostate |
Human |
Prostate carcinoma |
Adherent |
| CWR22Rv1/22rv1 |
Prostate |
Human |
Prostate carcinoma |
Adherent |
| LnCap ATCC |
Prostate |
Human |
Carcinoma |
Suspension |
| PC3 |
Prostate |
Human |
Grade IV, adenocarcinoma |
Adherent |
| A375 tom luc |
Skin |
Human |
Malignant melanoma |
Adherent |
| SkMel-2 |
Skin |
Human |
Malignant melanoma |
Adherent |
| SK-MEL-28 |
Skin |
Human |
Malignant melanoma |
Adherent |
| SK-MEL-5 |
Skin |
Human |
Malignant melanoma |
Adherent |
| UACC 257 |
Skin |
Human |
Melanoma |
Adherent |
| UACC-62 |
Skin |
Human |
Melanoma |
Adherent |
| NCI M14 |
Skin |
Human |
Melanoma |
Adherent |
| NHDF |
Skin |
Human |
Normal Human Dermal Fibroblasts |
Adherent |
| CUTL (CUTLL1) |
T lymphocyte |
Human |
Lymphoma |
suspension |
| CUTL lucNeo |
T lymphocyte |
Human |
Lymphoma |
suspension |
| MOLT-4 |
T lymphocyte |
Human |
Acute lymphoblastic leukemia |
Suspension |
| HT-1376 |
Urinary bladder |
Human |
Grade 3, carcinoma |
Adherent |
| RT4 |
Urinary bladder |
Human |
Transitional cell papilloma |
Adherent |
| T24 GFP luc |
Urinary bladder |
Human |
Transitional cell carcinoma |
|
| T24 Tom luc |
Urinary bladder |
Human |
Transitional cell carcinoma |
|
| T24T |
Urinary bladder |
Human |
Transitional cell carcinoma |
Adherent |
